Certified by Founder Lodge
Pitango
Israel - Herzliya
INVESTOR
2 Disclosed Funding Rounds $60,000,000
43 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Pitango is home to visionary entrepreneurs and groundbreaking companies from stealth mode to growth. We partner with exceptional founding teams via three parallel funds Pitango First, Pitango
| Company | Date | Round | Raised |
|---|---|---|---|
 Masterschool |
May, 18 ,2022 | Seed | $100,000,000 |
 Frontegg |
July, 28 ,2022 | Series B | $40,000,000 |
 Optibus |
May, 16 ,2022 | Series D | $100,000,000 |
 PayEm |
January, 25 ,2023 | Series A | $20,000,000 |
 Homethrive, Inc |
May, 23 ,2022 | Series B | $20,000,000 |
 AI21 Labs |
July, 12 ,2022 | Series B | $64,000,000 |
 Nexite |
May, 11 ,2022 | Series C | $67,000,000 |
 Finout |
June, 16 ,2022 | Unknown | $18,500,000 |
 ARMO |
April, 28 ,2022 | Series A | $30,000,000 |
 OpenEyes |
February, 16 ,2023 | Series A | $18,000,000 |
 D-ID |
March, 24 ,2022 | Series B | $25,000,000 |
| Masterschool |
May, 18 ,2022 | Seed | $100,000,000 |
 Visby Medical |
March, 01 ,2022 | Series E | $100,000,000 |
| Optibus |
May, 16 ,2022 | Series D | $100,000,000 |
 Sayata |
January, 24 ,2022 | Series A | $35,000,000 |
| Homethrive, Inc |
May, 23 ,2022 | Series B | $20,000,000 |
| Nexite |
May, 11 ,2022 | Series C | $67,000,000 |
 Zorro |
March, 31 ,2023 | Seed | $11,500,000 |
| ARMO |
April, 28 ,2022 | Series A | $30,000,000 |
 Patient21 |
May, 23 ,2023 | Series C | $107,718,000 |
| D-ID |
March, 24 ,2022 | Series B | $25,000,000 |
 DouxMatok |
May, 24 ,2023 | Series C | $30,000,000 |
| Visby Medical |
March, 01 ,2022 | Series E | $100,000,000 |
 Incredo |
May, 25 ,2023 | Series C | $30,000,000 |
| Sayata |
January, 24 ,2022 | Series A | $35,000,000 |
 Vertos Medical |
June, 08 ,2023 | Unknown | $26,000,000 |
| Zorro |
March, 31 ,2023 | Seed | $11,500,000 |
 SURGE Therapeutics |
July, 20 ,2023 | Series B | $32,000,000 |
| Patient21 |
May, 23 ,2023 | Series C | $107,718,000 |
 QuantHealth |
August, 31 ,2023 | Series A | $15,000,000 |
| DouxMatok |
May, 24 ,2023 | Series C | $30,000,000 |
 Variantyx |
October, 20 ,2023 | Unknown | |
| Incredo |
May, 25 ,2023 | Series C | $30,000,000 |
 Knostic |
April, 12 ,2024 | Pre-Seed | $3,300,000 |
| Vertos Medical |
June, 08 ,2023 | Unknown | $26,000,000 |
 GammaTime |
October, 24 ,2025 | Seed | $14,000,000 |
| SURGE Therapeutics |
July, 20 ,2023 | Series B | $32,000,000 |
| QuantHealth |
August, 31 ,2023 | Series A | $15,000,000 |
| Variantyx |
October, 20 ,2023 | Unknown | |
| Knostic |
April, 12 ,2024 | Pre-Seed | $3,300,000 |
| GammaTime |
October, 24 ,2025 | Seed | $14,000,000 |
 Altesa BioSciences, Inc. |
February, 20 ,2026 | Series B | $75,000,000 |
 Carefam |
March, 13 ,2026 | Unknown | $14,500,000 |
Cherry Ventures
Blue Bear Capital
Slow Ventures
Climate Capital
Eniac Ventures
Combat Medical Ltd | $3,472,639 | (Mar 13, 2026)
Ezra(2) | $8,000,000 | (Mar 13, 2026)
Arycs Technologies | $24,000,000 | (Mar 13, 2026)
Mantis Space | $10,000,000 | (Mar 13, 2026)
Freestyle | $10,000,000 | (Mar 13, 2026)
